Patent: 5,658,956
✉ Email this page to a colleague
Summary for Patent: 5,658,956
Title: | Bioadhesive-wound healing compositions and methods for preparing and using same |
Abstract: | The present invention pertains to therapeutic bioadhesive-wound healing compositions useful for treating wounds and increasing the proliferation and resuscitation rate of mammalian cells. The compositions comprise a bioadhesive agent and a therapeutically effective amount of a wound healing composition. In one embodiment the wound healing composition comprises (a) pyruvate; (b) an antioxidant; and (c) a mixture of saturated and unsaturated fatty acids. The therapeutic bioadhesive-wound healing compositions may further comprise medicaments such as antiviral agents, antikeratolytic agents, anti-inflammatory agents, antifungal agents, antibacterial agents, immunostimulating agents, and the like. The bioadhesive-wound healing compositions may be utilized in a wide variety of pharmaceutical products. This invention also relates to methods for preparing and using the bioadhesive-wound healing compositions and the pharmaceutical products in which the compositions may be used. |
Inventor(s): | Martin; Alain (Ringoes, NJ), Leung; Sau-Hung S. (Parsippany, NJ) |
Assignee: | Warner-Lambert Company (Morris Plains, NJ) |
Application Number: | 08/445,824 |
Patent Claims: | see list of patent claims |
Details for Patent 5,658,956
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Hemispherx Biopharma, Inc. | ALFERON N INJECTION | interferon alfa-n3 (human leukocyte derived) | Injection | 103158 | 10/10/1989 | ⤷ Try a Trial | 2014-08-19 |
Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | 06/04/2004 | ⤷ Try a Trial | 2014-08-19 | |
Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | 06/13/2008 | ⤷ Try a Trial | 2014-08-19 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |